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Despite the routine prescription of rate control therapy for atrial fibrillation (AF), clinical evi-
dence demonstrating a heart rate target is lacking. Aim of the present study was to run a
mathematical model simulating AF episodes with a different heart rate (HR) to predict hemo-
dynamic parameters for each situation.
Methods
The lumped model, representing the pumping heart together with systemic and pulmonary
circuits, was run to simulate AF with HR of 50, 70, 90, 110 and 130 bpm, respectively.
Results
Left ventricular pressure increased by 57%, from 33.92±37.56 mmHg to 53.15±47.56
mmHg, and mean systemic arterial pressure increased by 27%, from 82.66±14.04 mmHg to
105.3±7.6 mmHg, at the 50 and 130 bpm simulations, respectively. Stroke volume (from
77.45±8.50 to 39.09±8.08 mL), ejection fraction (from 61.10±4.40 to 39.32±5.42%) and
stroke work (SW, from 0.88±0.04 to 0.58±0.09 J) decreased by 50, 36 and 34%, at the 50
and 130 bpm simulations, respectively. In addition, oxygen consumption indexes (rate pres-
sure product – RPP, tension time index per minute – TTI/min, and pressure volume area per
minute – PVA/min) increased from the 50 to the 130 bpm simulation, respectively, by 186%
(from 5598±1939 to 15995±3219 mmHg/min), 56% (from 2094±265 to 3257±301 mmHg s/
min) and 102% (from 57.99±17.90 to 117.4±26.0 J/min). In fact, left ventricular efficiency
(SW/PVA) decreased from 80.91±2.91% at 50 bpm to 66.43±3.72% at the 130 bpm
HR simulation.
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Conclusion
Awaiting compulsory direct clinical evidences, the present mathematical model suggests
that lower HRs during permanent AF relates to improved hemodynamic parameters, cardiac
efficiency, and lower oxygen consumption.
Introduction
Atrial fibrillation (AF), the most common sustained tachyarrhythmia, affects 1% to 2% of the
general population [1]. In case the arrhythmia progresses to permanent [2], on top of oral anti-
coagulants, rate control is recommended to reduce symptoms and improve quality of life [3].
Despite the routine prescription of AF rate control therapy [4], clinical evidence demonstrating
a heart rate target is lacking. Only the RACE II clinical trial [5, 6] suggested that lenient and
strict rate control strategies may not differ in terms of mid-term cardiovascular outcomes.
Awaiting further clinical evidences, the use of a novel mathematical model [7], validated
through systematic comparison with directly measured parameters and able to simulate the re-
sponse of the cardiovascular system in sinus rhythm and AF, holds the potential to theoretical-
ly suggest an optimal heart rate to target.
Aim of the present study was to run the mathematical model during simulated AF episodes




The present lumped model, consisting of a network of compliances, resistances, and induc-
tances, simulates the pumping heart together with the systemic and pulmonary circuits [7].
The resultant differential system is composed, for each cardiac chamber or vascular section, by
an equation for the mass conservation, an equation of motion, and a linear state equation, and
is expressed in terms of pressure, P, volume, V, and flow rate, Q. The differential equations are
numerically solved through a multistep adaptative solver for stiff problems, based on the
ode15s Matlab function [8]. All hemodynamic parameters and plots are computed and imple-
mented in Matlab, as well. The model has been compared with more than thirty different clini-
cal state of the art studies, providing an overall good agreement in predicting the impact of AF
[7].
Both atria are maintained passive to mimic the loss of atrial kick, while RR values are ex-
tracted from an exponentially modified Gaussian distribution [7], which is the most common
RR distribution recorded during AF [9]. By varying the HR from 50 to 130 bpm, each distribu-
tion is built keeping the coefficient of variation, cv = σ/μ (03C3: standard deviation, μ: mean of
the RR distribution), equal to 0.24, which is the typical value observed during AF beating [10].
The resulting probability distribution functions for 50, 70, 90, 110, and 130 bpm, are shown in
Fig. 1.
For every HR, 5000 cardiac cycles are computed, which allows the statistical stationarity of
the modeling results. Therefore, all the variables of the present work are intended as averaged
over 5000 periods.
AMathematical Model for AF Rate Control
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Definitions of variables
In terms of pressure and volume, by evaluating also end-systolic (es) and end-diastolic (ed) val-
ues, as well as left ventricular pressure peak values (maximum and minimum), the following
parameters are computed: left atrial pressure (Pla, Plaed, Plaes), left atrial volume (Vla, Vlaed,
Vlaes), left ventricular pressure (Plv, Plved, Plves, Plv,max, Plv,min), left ventricular volume (Vlv,
Vlved, Vlves), systemic arterial pressure (Psas, Psas,syst, Psas,dias), pulmonary arterial (Ppas, Ppas,syst,
Ppas,dias) and venous (Ppvn) pressures. End-systolic values refer to the instant defined by the clo-
sure of the aortic valve, while end-diastolic values correspond to the closure of the mitral valve.
Concerning left ventricle performance the following parameters are also computed: stroke
volume, SV = Vlved—Vlves, ejection fraction, EF = SV/Vlved x 100, stroke work, SW, evaluated as
the area within the left ventricle pressure-volume loop, and cardiac output, CO = SV x HR. To
estimate the oxygen consumption, the following indirect measurements were computed [11]:
rate pressure product, RPP = Psas,syst x HR, tension time index per minute [12], TTI/min = Plv,
mean x RR x HR, and pressure volume area per minute [13], PVA/min = (PE + SW) x HR,
where PE = Plves x (Vlves – Vlv,un)/2—Plved x (Vlved—Vlv,un)/4 is the elastic potential energy (Vlv,
un = 5 ml is the unstressed left ventricle volume), while SW is the stroke work. The left ventricu-
lar efficiency is defined by the ratio SW/PVA.
Results
The mathematical model was run to simulate AF with heart rate (HR) of 50, 70, 90, 110 and
130 bpm, respectively. All computed parameters, stratified by HR, are listed in Table 1. Left
Fig 1. RR distributions. Probability distribution functions of RR interval for the different simulations
are reported.
doi:10.1371/journal.pone.0119868.g001
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ventricular pressure (Plv), systemic pressure (Psas) and cardiac mechano-energetic indexes (e.g.
SV, EF, SW and ventricular efficiency) varied more than 15% within the different
HR simulations.
Mean value and representative examples of temporal series of left ventricular pressure are
shown in Fig. 2: Plv increased by 57%, from 33.92±37.56 mmHg to 53.15±47.56 mmHg at the
50 and 130 bpm simulations, respectively.
Table 1. Mean and standard deviation of computed parameters stratified by each simulation.
Parameters Results of simulations Maximum % variationa
50 bpm 70 bpm 90 bpm 110 bpm 130 bpm
Pla [mmHg] 9.81 ± 0.81 9.39 ± 0.77 9.16 ± 0.76 9.07 ± 0.76 9.08 ± 0.77 -8
Plaes [mmHg] 11.00 ± 0.35 10.41 ± 0.25 10.08 ± 0.17 9.91 ± 0.13 9.85 ± 0.13 -10
Plaed [mmHg] 10.10 ± 0.21 9.75 ± 0.14 9.59 ± 0.09 9.53 ± 0.10 9.53 ± 0.09 -6
Vla [ml] 62.76 ± 5.41 59.91 ± 5.16 58.42 ± 5.04 57.83 ± 5.07 57.88 ± 5.17 -8
Vlaes [ml] 70.68 ± 2.31 66.72 ± 1.68 64.52 ± 1.11 63.40 ± 0.88 63.00 ± 0.84 -11
Vlaed [ml] 64.68 ± 1.41 62.35 ± 0.95 61.26 ± 0.62 60.89 ± 0.65 60.89 ± 0.63 -6
Plv [mmHg] 33.92 ± 37.56 40.16 ± 42.46 45.38 ± 45.42 49.69 ± 46.98 53.15 ± 47.56 +57
Plves [mmHg] 91.75 ± 3.92 95.74 ± 2.78 96.86 ± 2.25 96.51 ± 2.09 95.46 ± 1.84 +6
Plved [mmHg] 15.46 ± 0.75 16.32 ± 0.97 17.24 ± 1.08 18.21 ± 1.14 19.08 ± 1.02 +23
Plv,max [mmHg] 103.9 ± 5.1 111.1 ± 3.9 115.1 ± 2.6 117.0 ± 1.8 117.5 ± 1.5 +13
Plv,min [mmHg] 4.85 ± 0.11 4.77 ± 0.06 4.79 ± 0.05 4.82 ± 0.05 4.84 ± 0.04 0
Vlv [ml] 101.4 ± 33.1 93.72 ± 28.97 88.50 ± 25.79 84.24 ± 23.27 80.53 ± 21.15 -21
Vlves [ml] 48.94 ± 2.88 53.53 ± 2.76 56.70 ± 2.15 58.54 ± 1.54 59.35 ± 1.16 +21
Vlved [ml] 126.4 ± 5.7 117.2 ± 6.1 110.1 ± 6.5 103.9 ± 7.2 98.45 ± 7.11 -22
Psas [mmHg] 82.66 ± 14.04 93.35 ± 11.65 99.72 ± 9.83 103.4 ± 8.5 105.3 ± 7.6 +27
Psas,dias [mmHg] 64.99 ± 8.90 78.20 ± 7.47 86.46 ± 5.88 91.73 ± 4.74 94.92 ± 3.93 +46
Psas,syst [mmHg] 103.8 ± 5.1 111.0 ± 3.9 115.0 ± 2.6 116.9 ± 1.8 117.4 ± 1.5 +13
Ppas [mmHg] 18.72 ± 5.03 19.62 ± 4.25 20.18 ± 3.68 20.54 ± 3.25 20.78 ± 2.96 +11
Ppas,dias [mmHg] 12.67 ± 1.26 14.05 ± 1.38 15.18 ± 1.32 16.06 ± 1.19 16.73 ± 1.08 +32
Ppas,syst [mmHg] 27.43 ± 0.95 26.51 ± 0.77 25.96 ± 0.68 25.58 ± 0.63 25.31 ± 0.60 -8
Ppvn [mmHg] 10.20 ± 0.65 9.83 ± 0.56 9.64 ± 0.49 9.57 ± 0.44 9.59 ± 0.41 -6
SV [ml] 77.45 ± 8.50 63.61 ± 8.84 53.39 ± 8.43 45.32 ± 8.54 39.09 ± 8.08 -50
EF [%] 61.08 ± 4.40 54.03 ± 5.22 48.19 ± 5.27 43.24 ± 5.70 39.32 ± 5.42 -36
SW [J] 0.88 ± 0.04 0.81 ± 0.07 0.73 ± 0.08 0.65 ± 0.10 0.58 ± 0.09 -34
CO [l/min] 4.02 ± 0.66 4.57 ± 0.58 4.88 ± 0.47 5.03 ± 0.43 5.11 ± 0.35 +27
RPP [mmHg/min] 5598 ± 1939 8330 ± 2612 10977 ± 2953 13601 ± 3292 15995 ± 3219 +186
TTI/min [mmHg s/min] 2094 ± 265 2479 ± 304 2793 ± 310 3053 ± 314 3257 ± 301 +56
PVA/min [J/min] 57.99 ± 17.90 78.82 ± 20.66 95.17 ± 22.41 107.9 ± 24.7 117.4 ± 26.0 +102
SW/PVA [%] 80.91 ± 2.91 76.42 ± 3.43 72.61 ± 3.50 69.20 ± 4.05 66.43 ± 3.72 -18
Pla, left atrium pressure; Plaes, left atrium end-systolic pressure; Plaed, left atrium end-diastolic pressure; Vla, left atrium volume; Vlaes, left atrium end-
systolic volume; Vlaed, left atrium end-diastolic volume; Plv, left ventricular pressure; Plves, left ventricular end-systolic pressure; Plved, left ventricular end-
diastolic pressure; Plv,max, left ventricular maximum pressure; Plv,min, left ventricular minimum pressure; Vlv, left ventricular volume; Vlves, left ventricular
end-systolic volume; Vlved, left ventricular end-diastolic volume; Psas, mean systemic arterial pressure; Psas,dias, diastolic systemic arterial pressure; Psas,
syst, systolic systemic arterial pressure; Ppas, mean pulmonary arterial pressure; Ppas,dias, diastolic pulmonary arterial pressure; Ppas,syst, systolic pulmonary
arterial pressure; Ppvn, pulmonary vein pressure; SV, stroke volume; EF, ejection fraction; SW, stroke work; CO, cardiac output; RPP, rate pressure
product; TTI/min, tension time index per minute; PVA/min, pressure volume area per minute; SW/PVA, left ventricular efficiency.
a parameters showing a maximum % variation above ±15% with respect to reference (50 bpm) are reported in bold.
doi:10.1371/journal.pone.0119868.t001
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Systemic pressure variations are illustrated in Fig. 3. Mean Psas increased by 27%, from
82.66±14.04 mmHg to 105.3±7.6 mmHg at the 50 and 130 bpm simulations, respectively. In
details, systolic pressure (Psas,syst) shifted from 103.8±5.1 mmHg (50 bpm) to 117.4±1.5 mmHg
(130 bpm), and diastolic pressure (Psas,dias) from 64.99±8.90 mmHg (50 bpm) to 94.92±3.93
mmHg (130 bpm).
Eventually, heart performance was assessed by several mechanic and energetic parameters
(Fig. 4). Concerning left ventricle mechanics, SV (from 77.45±8.50 to 39.09±8.08 mL), EF
(from 61.10±4.40 to 39.32±5.42%) and SW (from 0.88±0.04 to 0.58±0.09 J) decreased by 50,
36 and 34%, at the 50 and 130 bpm simulations, respectively. In addition, oxygen consump-
tion indexes (RPP, TTI/min and PVA/min) increased from the 50 to the 130 bpm simulation,
respectively, by 186% (from 5598±1939 to 15995±3219 mmHg/min), 56% (from 2094±265
to 3257±301 mmHg s/min) and 102% (from 57.99±17.90 to 117.4±26.0 J/min). In fact, left
Fig 2. Left ventricular pressure. (a) mean left ventricular pressure as function of heart rate; (b) representative left ventricular pressure time series of 50 and
130 bpm simulations. Plv, left ventricular pressure; Plves, left ventricular end-systolic pressure; Plved, left ventricular end-diastolic pressure.
doi:10.1371/journal.pone.0119868.g002
Fig 3. Systemic arterial pressure. (a) mean values of systemic arterial pressure as function of heart rate; (b) representative systemic arterial pressure time
series of 50 and 130 bpm simulations. Psas, mean systemic arterial pressure; Psas,dias, diastolic systemic arterial pressure; Psas,syst, systolic systemic
arterial pressure.
doi:10.1371/journal.pone.0119868.g003
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ventricular efficiency (SW/PVA) decreased from 80.91±2.91% at 50 bpm to 66.43±3.72% at
the 130 bpm HR simulation.
Discussion
Based on the presented mathematical simulations a slower (50 bpm), compared to higher (130
bpm), HR during AF relates to improved ventricular pressure, systemic pressure and left ven-
tricular efficiency (e.g. SW/PVA).
Given several clinical trial (AFFIRM [14, 15], RACE [16]) proving, within patients with per-
sistent AF, that rate is not inferior to rhythm control in terms of mortality from cardiovascular
causes, AF rate control therapy is widely prescribed. Despite this, clinical evidence demonstrat-
ing a clear heart rate target is lacking. A randomized multicenter non-inferiority clinical trial,
the RACE II [5, 6], suggested that, in patients with permanent AF, lenient rate control (target
resting HR below 110 bpm) is not inferior to strict (target resting HR below 80 and during
moderate exercise below 110 bpm) in terms of cardiovascular outcomes. Moreover, substudies
Fig 4. Mechanic and energetic indexes of left heart.Mean values of mechanic and energetic indexes are plotted as function of heart rate. (a) stroke
volume, SV; (b) ejection fraction, EF; (c) stroke work, SW; (d) rate pressure product, RPP; (e) tension time index per minute, TTI/min; (f) pressure volume
area per minute, PVA/min; (g) left ventricular efficiency, SW/PVA.
doi:10.1371/journal.pone.0119868.g004
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of this trial also underlined that stringency of rate control does not influence neither cardiac re-
modeling [17] nor quality of life [18].
However, as previously highlighted [19], the RACE II study presented several limitations.
First, the modest difference in average heart rates achieved in the lenient and strict control
groups (85 and 75 bpm, respectively) and the limited sample size of the study (about 300 pa-
tients per group). In addition, the number of patients who met the primary outcome of the
study (a composite of death from cardiovascular causes, hospitalization for heart failure, stroke,
systemic embolism, major bleeding, arrhythmic events, cardiac arrest, life-threatening adverse
effects of rate-control drugs and implantation of a pacemaker or cardioverter–defibrillator)
was small, most probably due to the low-risk population enrolled (e.g. patients with previous
stroke were excluded).
Awaiting mandatory further clinical evidences, the present study aims at investigating, with
a model-based approach, the global response of the cardiovascular system during episodes of
AF at different ventricular rates. The present mathematical model has previously been thor-
oughly validated and showed strong concordance of the computed parameters with several
data directly measured in vivo [7]. However, two considerations should be kept in mind: first,
the model predicts hemodynamic effects of AF in absence of other associated conditions or pa-
thologies, e.g. hypertension [20], that could themselves affect cardiovascular parameters; sec-
ond, the model does not consider the impact that rate control drugs (e.g. digoxin, beta
blockers, non-dihydropiridine calcium channel blockers) could exert on the cardiovascular sys-
tem. As a consequence, the reported parameters differ among each simulation strictly depend-
ing on ventricular rate.
Left ventricular pressure greatly increased at faster ventricular rates (as shown in Fig. 2).
The relative shortening of diastolic time at the fastest HR simulations, in our opinion, mainly
drives this finding. In fact, the increase in mean Plved values (below 4 mmHg) does not balance
the dramatic absolute and relative increase of the mean Plv (nearly 20 mmHg). Moreover, Plves
and both pressure peak values do not significantly vary (minimum pressure peaks remain even
constant as HR increases).
Contextually, it is important to underline that the reduction in Vlv is mainly founded on the
decrease of Vlved. In general, ventricular filling is known to be reduced during AF, due to loss of
the atrial kick, however, the contribution of this cardiac phase is highly dependent on heart
rate, becoming fundamental in case it is increased (e.g. physical exercise [21]), due to the fact
that passive ventricular filling in early diastole is reduced concomitantly to a shortened diastol-
ic time. The same mechanisms may, in fact, explain the greater Vlved reduction in AF simula-
tions with a faster ventricular rate. In addition higher HRs lead also to a quite strong rise of
Psas, most probably related to an increase in diastolic pressure accounting for a greater afterload
for the left heart to overcome.
Based on the model’s predictions, lower HRs during AF relate to improved mechanic and
energetic indexes. First, the reduction of SV and SW seen with the progressively higher HRs
translates into a left ventricle’s EF decrease by far greater than the physiological reduction ex-
pected [22]. Furthermore, the increase in oxygen consumption indexes is relevant with the pro-
gressively higher HRs simulations. In fact, RPP triplicates and PVA/min doubles their mean
values from the lowest (50 bpm) to the highest (130 bpm) HR simulation, extensively support-
ing that faster ventricular rates relate to a rise in cardiac energetic expense not associated with a
concomitant increase in mechanical performance (e.g. CO). Finally, left ventricle efficiency
(SW/PVA) proved to significantly decrease at progressively higher HRs simulated during the
AF episodes, well synthesizing how mechanic and energetic indexes of the heart present an im-
proved profile at slower HRs that allow the fibrillating heart to better convert energy into
external work.
AMathematical Model for AF Rate Control
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Eventually, although the present model currently does not present the ability to predict such
setting, during exertion (a situation in which inotropism and chronotropism increase due to
sympathetic stimulation) the reduction in left ventricle efficiency caused by faster HR may be-
come even more limiting, perhaps, at least partially, accounting for the lower resistance to ef-
fort common in subjects with AF.
Limitations
In addition to what previously discussed, the following limitations must be taken in account.
First, the present mathematical model simulates a denervated heart; the effects of the autonom-
ic nervous system on cardiac performance are therefore not included. Second, due to difficul-
ties in the mathematical modelling of the coronary arteries dynamics, in the present model the
coronary circle is not taken in account. Third, the present model-based approach predicts the
global response of the cardiovascular system during episodes of AF at different HRs. For the
purpose of the present study we considered “relevant” variations (maximum % variation),
within the different HR simulations, above 15%. Concerning parameters not reaching this
limit, such as left atrial parameters (Pla and Vla) or pulmonary pressures (Ppas and Ppvn) it can-
not be concluded if either different HRs do not significantly affect their values, or the present
model may not be able to detect variations.
Conclusion
In conclusion, awaiting compulsory direct clinical evidences, the present mathematical model
suggests that lower HRs during permanent AF relates to improved hemodynamic parameters
and cardiac efficiency, resulting in lower oxygen consumption for a given cardiac work.
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